S7. Amyloid-lowering Immunotherapies for Down Syndrome-related Alzheimer’s disease: Neuropathological Insights and Vascular Safety in Clinical Trials
Tracks
Room 1
| Thursday, June 18, 2026 |
| 9:30 - 11:30 |
| Room 1 |
Speaker
Dr. Lisi Flores Aguilar
Postdoctoral Scholar
University of California, Irvine
Neuropathology of the blood-brain barrier across the AD continuum in Down syndrome: implications for amyloid lowering therapies.
Biography
Donna M Wilcock
Biomarkers and vascular burden in DS: tools to inform safety and clinical trial readiness.
Biography
Javier Arranz
Clinical perspectives and case reports: understanding safety and indications of anti-amyloid therapies in DS.
Biography
Prof. Michael Rafii
Keck School Of Medicine Of USC
Amyloid-immunotherapy clinical trials in Down syndrome: design, safety considerations, and lessons for the field.
Biography
Dr. Isabel Barroeta
Faculty Neurologist
HOSPITAL DE LA SANTA CREU I SANT PAU (Centre CERCA)
Title to be determined
Biography
|
